Investors

Financials & Filings

Filing date Form Description Filing Group View
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
S-1

Registration statement for face-amount certificate companies

Registration Statements
REGDEX/A

REGDEX/A

Other
REGDEX

REGDEX

Other
REGDEX/A

REGDEX/A

Other
REGDEX

REGDEX

Other

Data provided by Kaleidoscope.

GNI Group, Ltd. (2160:Tokyo) (“GNI Japan”) holds an indirect, controlling interest in Gyre Therapeutics, Inc. From time to time, GNI Japan will disclose historical and forward looking information, which will include information about our business. We may not have previously disclosed such information. Please refer to https://www.gnipharma.com/ir/yuho/ for GNI Japan’s Investor Information and Securities Reports.